Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.20B | 33.77B | 28.57B | 26.84B | 27.30B | 27.69B |
Gross Profit | 4.13B | 4.31B | 3.77B | 3.37B | 4.27B | 4.75B |
EBITDA | 1.52B | 4.01B | 1.40B | 879.00M | 1.65B | 2.39B |
Net Income | 538.00M | 2.19B | 415.00M | 123.00M | 775.00M | 1.33B |
Balance Sheet | ||||||
Total Assets | 37.93B | 37.76B | 33.67B | 28.79B | 27.79B | 25.05B |
Cash, Cash Equivalents and Short-Term Investments | 3.08B | 3.08B | 2.20B | 2.32B | 3.25B | 1.48B |
Total Debt | 13.52B | 10.78B | 9.02B | 6.45B | 4.95B | 4.69B |
Total Liabilities | 27.59B | 25.44B | 23.26B | 18.86B | 17.96B | 15.73B |
Stockholders Equity | 10.34B | 12.31B | 10.41B | 9.93B | 9.83B | 9.31B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -4.03B | -2.51B | -2.21B | 2.32B | -1.01B |
Operating Cash Flow | 0.00 | -2.33B | -1.09B | -1.16B | 3.15B | -137.00M |
Investing Cash Flow | 0.00 | 1.70B | -1.46B | -1.10B | -1.08B | -878.00M |
Financing Cash Flow | 0.00 | 1.51B | 2.42B | 1.33B | -287.00M | 912.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥9.93B | 11.66 | 4.79% | 5.27% | -26.42% | ||
82 Outperform | ¥8.36B | 5.02 | 0.26% | 15.97% | 3.62% | ||
79 Outperform | ¥4.03B | 7.60 | 3.55% | -9.83% | 33.02% | ||
71 Outperform | ¥9.11B | 5.31 | 0.32% | 21.36% | 55.82% | ||
63 Neutral | ¥9.26B | 4.24 | 2.49% | 18.22% | 430.92% | ||
62 Neutral | ¥9.52B | 5,192.31 | ― | -0.40% | -98.14% | ||
58 Neutral | HK$13.95B | 4.43 | -3.01% | 7.31% | 3.67% | -54.16% |